Phase II Trial of Erlotinib for Japanese Patients With Previously Treated Non-small-cell Lung Cancer Harboring EGFR Mutations: Results of Lung Oncology Group in Kyushu (LOGiK0803).

Details

Language :

English

ISSN :

03682811

Volume :

43

Issue :

6

Database :

Complementary Index

Journal :

Japanese Journal of Clinical Oncology

Publication Type :

Academic Journal

Accession number :

87825785

Full Text :

https://doi.org/10.1093/jjco/hyt056